☆ 4.8 Article

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d

FRONTIERS IN IMMUNOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease

Nadine Gauchel et al.

Summary: This study compared the levels of complement system components in COVID-19 patients and other groups, revealing that COVID-19 patients had significantly elevated levels of CS components 5a and 4, increased levels of vWF antigen, and a significant correlation with vWF antigen, suggesting a pronounced immune inflammatory response in COVID-19 disease.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

添加到收藏夹

Article Immunology

Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality

Alexander Leatherdale et al.

Summary: The hyperacute thrombo-inflammatory response triggered by SARS-CoV-2 in COVID-19 is poorly understood, but evidence suggests that overactivation of complement plays a role. This study found that severely ill COVID-19 patients have increased and persistent activation of the complement system, particularly through the alternative pathway. Complement activation biomarkers may be valuable in assessing disease severity and predicting mortality.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2022)

添加到收藏夹

Review Immunology

Crosstalk between the renin-angiotensin, complement and kallikrein-kinin systems in inflammation

Zivile Bekassy et al.

Summary: This review explores the complex interactions between the renin-angiotensin system, complement system, and kallikrein-kinin system, as well as their dysregulation in different conditions and therapeutic implications. Various mediators modulate the balance between vascular tone, inflammation, coagulation, and thrombosis during severe inflammatory and infectious diseases. These systems play important roles in cell biological functions, such as regulating vascular tone, inflammation, and thrombosis.

NATURE REVIEWS IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Persistence of High Levels of Serum Complement C5a in Severe COVID-19 Cases After Hospital Discharge

Yaiza Senent et al.

Summary: This study found that serum C5a levels remain high in severe cases of COVID-19 and are associated with the presence of respiratory symptoms after hospital discharge, suggesting a potential role for C5a in the long-term effects of the infection.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population

Farhan S. Cyprian et al.

Summary: This study aimed to identify high-risk patients at the time of SARS-COV-2 infection who may develop severe disease associated with low survival using blood parameters, including inflammation and coagulation mediators, vital signs, and pre-existing comorbidities.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

A Conformational Change of Complement C5 Is Required for Thrombin-Mediated Cleavage, Revealed by a Novel Ex Vivo Human Whole Blood Model Preserving Full Thrombin Activity

Per H. Nilsson et al.

Summary: Thrombin activation of C5 links thrombosis to inflammation, but in a blood model using GPRP anticoagulation, Thrombin was unable to cleave native C5, suggesting that its cleavage of C5 may be restricted to certain pathophysiological conditions.

JOURNAL OF IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality

Bandar Alosaimi et al.

Summary: This study revealed elevated levels of complement proteins and inflammatory cytokines in critical COVID-19 patients, along with decreased levels of factor I and C4-BP. Higher levels of C5a, C3a, and factor P were associated with non-survival patients, along with increased IL-1 beta, IL-6, and IL-8 levels. These findings suggest the potential prognostic utility of the complement system in predicting COVID-19 severity and mortality.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Letter Medicine, General & Internal

Complement inhibition in severe COVID-19-Blocking C5a seems to be key: Author's reply

Djillali Annane et al.

ECLINICALMEDICINE (2021)

添加到收藏夹

Article Allergy

Complement activation in patients with COVID-19: A novel therapeutic target

Massimo Cugno et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

Wenhua Liang et al.

JAMA INTERNAL MEDICINE (2020)

添加到收藏夹

Review Hematology

COVID-19: A collision of complement, coagulation and inflammatory pathways

Anoop J. Chauhan et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)

添加到收藏夹

Article Hematology

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition

Jia Yu et al.

BLOOD (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

Julien Carvelli et al.

NATURE (2020)

添加到收藏夹

Article Medicine, General & Internal

Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study

Djillali Annane et al.

ECLINICALMEDICINE (2020)

添加到收藏夹

Article

Complement C4d-specific antibodies for the diagnosis of lung cancer

Daniel Ajona et al.

Oncotarget (2017)

添加到收藏夹

Article Rheumatology

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus

Myriam Martin et al.

ARTHRITIS RESEARCH & THERAPY (2017)

添加到收藏夹

Article Rheumatology

The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis

Andre Struglics et al.

ARTHRITIS RESEARCH & THERAPY (2016)

添加到收藏夹

Article Rheumatology

Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis

Marcin Okroj et al.

ARTHRITIS RESEARCH & THERAPY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation

Anna M. Blom et al.

MOLECULAR IMMUNOLOGY (2015)

添加到收藏夹

Review Immunology

Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH

Hany Ibrahim Kenawy et al.

FRONTIERS IN IMMUNOLOGY (2015)

添加到收藏夹

Review Biochemistry & Molecular Biology

An international serum standard for application in assays to detect human complement activation products

Grethe Bergseth et al.

MOLECULAR IMMUNOLOGY (2013)

添加到收藏夹

Article Hematology

Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway

Michael J. Krisinger et al.

BLOOD (2012)

添加到收藏夹

Article Immunology

Complement activation in septic baboons detected by neoepitope-specific assays for C3b/iC3b/C3c, C5a and the terminal C5b-9 complement complex (TCC)

T. E. MOLLNES et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)

添加到收藏夹

Article Immunology

Molecular Intercommunication between the Complement and Coagulation Systems

Umme Amara et al.

JOURNAL OF IMMUNOLOGY (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Generation of C5a in the absence of C3: a new complement activation pathway

Markus Huber-Lang et al.

NATURE MEDICINE (2006)

添加到收藏夹

Article Medicine, General & Internal

Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria

P Hillmen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.